Summary
Galectins, β-galactoside binding proteins, expressed selectively in human breast carcinoma are attractive targets to employ lectin-aimed therapeutics. We examined β-galactoside binding potency of neoplastic cells using fluorescein-labelled synthetic glycoconjugates as probes for flow cytometry. As a result, surface β-galactoside binding proteins/galectins were discovered on mouse mammary carcinoma cells in vitro and in vivo unlike non-malignant cells from the several tissues; and asialo-GM1 ganglioside carbohydrate part - containing probe was the most specific one. However, in liver and lung metastatic cells galectins seem to be expressed within cytoplasm and/or nuclei. Galectin expression correlated directly with aggressive tumour potential in the A/Sn transplantable model similar to findings in several human breast carcinoma cell lines. However, galectin expression was reduced during tumour progression in more aggressive forms of spontaneous BLRB mammary carcinomas like it was shown for human breast carcinoma specimens. Analysis of the histopathological data led, however, to the conclusion that galectin expression hardly might be a suitable marker of aggressiveness of heterogeneous mammary carcinomas as the observed level of galectin expression is influenced by the amount of the stroma in a tumour sample and/or probably, galectin expression inversely correlates with tumour aggressiveness during the initial and advanced steps of mammary tumour progression. We conclude that surface β-galactoside binding proteins/galectins that are selectively expressed during mouse mammary carcinoma progression, similarly to human breast carcinomas, seem to be proper targets for asialo-GM1-vectored cytotoxics and our mouse model system might be a relevant instrument to further test novel modes of anti-breast cancer therapy.
Similar content being viewed by others
Abbreviations
- aGM1, Galβ1-3GalNAcβ1-4Galβ1-4Glcβ:
-
asialo-GM1 ganglioside carbohydrate part
- βGBP:
-
β-galactoside binding protein
- BC:
-
breast cancer
- BSA:
-
bovine serum albumin
- Glyc-PAA-fluo :
-
polyacrylamide glycoconjugate probes labeled with fluorescein
- LacNAc:
-
Galβ1-4GlcNAcβ, lactosamine disaccharide
- PAS:
-
Periodic Acid -Schiff staining
- PBS:
-
phosphate buffered saline
- PBA:
-
PBS containing 0.2% BSA
- PI:
-
proliferation index
- SiaLex :
-
Neu5Acα2-3 Galβ1-4(Fucα1-3)GlcNAc tetrasaccharide
- Tαα :
-
Galβ1-3GalNAcα disaccharide
- Versene solution:
-
PBS containing 0.02% EDTA
References
M Morrow W Gradishar (2002) ArticleTitleBreast cancer Br Med J 324 410–414
HM Ogmundsdottir (2001) ArticleTitleImmune reaction to breast cancer: for better or for worse? Arch Immunol Ther Exp 49 IssueIDsuppl. 2 S75–S81
TA Pluncett I Correa DW Miles J Taylor-Papadimitriou (2001) ArticleTitleBreast cancer and the immune system: opportunities and pitfalls J Mammary Gland Biol Neoplasia 6 467–475 Occurrence Handle10.1023/A:1014743232598 Occurrence Handle12013535
JR Harris M Morrow G Bonadonna (1993) Cancer of the breast VT De Vita S Helman SA Rosenberg (Eds) Cancer. Principles and Practice of Oncology JB Lippincot Philadelphia 1264–1332
RO Dillman LD Beutel C De Leon ShK Nayak (2001) ArticleTitleShort-term tumour cell lines from breast cancer for use as autologous tumour cell vaccines in the treatment of breast cancer Cancer Biotherapy Radiopharm 16 205–211 Occurrence Handle10.1089/10849780152389393
NV Bovin (1998) ArticleTitlePolyacrylamide-based neoglycoconjugates as tools in glycobiology Glycoconj J 15 431–446 Occurrence Handle10.1023/A:1006963717646 Occurrence Handle9881745
N Yamazaki S Kojima NV Bovin S Andre S Gabius HJ Gabius (2000) ArticleTitleEndogenous lectins as targets for drug delivery Adv Drug Deliv Rev 43 225–244 Occurrence Handle10.1016/S0169-409X(00)00071-5 Occurrence Handle10967228
EL Vodovozova EV Moiseeva GK Grechko GP Gayenko NE Nifant’ev NV Bovin JG Molotkovsky (2000) ArticleTitleAntitumor activity of cytotoxic liposomes equipped with selectin ligand SiaLex, in mouse mammary adenocarcinoma Eur J Cancer 36 942–949 Occurrence Handle10.1016/S0959-8049(00)00029-0 Occurrence Handle10785601
GA Rabinovich (1999) ArticleTitleGalectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy Cell Death Different 6 711–721 Occurrence Handle10.1038/sj.cdd.4400535
A Varki R Cummings J Esko H Freeze G Hart J Marth (Eds) (1999) Essentials of Glycobiology, Consortium of Glycobiology Editors La Jolla California
A Dangue I Camby R Kiss (2002) ArticleTitleGalectins and cancer Biochim Biophys Acta 1572 285–293 Occurrence Handle12223276
L Chiariotti P Salvatore R Frunzio CB Bruni (2004) ArticleTitleGalectin genes: regulation of expression Glycoconj J 19 441–449 Occurrence Handle10.1023/B:GLYC.0000014073.23096.3a Occurrence Handle14758067
SK Khaldoyanidi VV Glinsky L Sikora AB Glinskii VV Mossine TP Quinn GV Glinsky P Sriramarao (2003) ArticleTitleMDA-MB-435 human breast carcinoma cell homo- and heterotypic adhesion under flow conditions is mediated in part by Thomsen-Friedenreich antigen-galectin-3 interactions J Biol Chem 278 4127–4134 Occurrence Handle10.1074/jbc.M209590200 Occurrence Handle12438311
YK Song TR Billiar YJ Lee (2002) ArticleTitleRole of galectin-3 in breast cancer metastasis: involvement of nitric oxide Am J Pathol 160 1069–1075 Occurrence Handle11891203
H Idikio (1998) ArticleTitleGalectin-3 expression in human breast carcinoma: correlation with cancer histological grade Int J Oncol 12 1287–1290 Occurrence Handle9592187
F Vanden Brule S Califice V Castronovo (2004) ArticleTitleExpression of galectins in cancer: a critical review Glycoconj J 19 537–542 Occurrence Handle10.1023/B:GLYC.0000014083.48508.6a Occurrence Handle14758077
H-RCh Kim Hu-M Lin H Biliran A Raz (1999) ArticleTitleCell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells Cancer Res 59 4148–4154 Occurrence Handle10463621
A Paz R Haklai G Elad-Sfadia E Ballan J Kloog (2001) ArticleTitleGalectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation Oncogene 20 7486–7493 Occurrence Handle10.1038/sj.onc.1204950 Occurrence Handle11709720
P Nangia-Makker Y Honjo R Sarvis S Akahani V Hogan KJ Pienta A Raz (2000) ArticleTitleGalectin-3 induces endothelial cell morphogenesis and angiogenesis Am J Pathol 156 899–909 Occurrence Handle10702407
Mouse Genome Informatics http://www.informatics.jax.org/external/festing/mouse/docs/BLRB.shtml and http://www. informatics.jax.org/external/festing/mouse/docs/CBRB.shtml
EV Moiseeva IB Merkulova C Bijleveld J-W Koten AI Miroshnikov W Den Otter (2003) ArticleTitleTherapeutic effect of single peritumoural dose of IL-2 on transplanted murine breast cancer Cancer Immunol Immunother 52 487–496 Occurrence Handle10.1007/s00262-003-0385-8 Occurrence Handle12719897
Moiseeva E, Chaadaeva A, Bojenko V, Mehdipour P, Den Otter W: Mouse naturally arising mammary cancer: promising link to familial set of breast cancer. In: Proceedings of the First International Congress on Cancer Genetics, Tehran University of Medical Sciences, December 13–16 2003, Publisher of Deputy Research, Tehran, 2003, p 102.
E Rapoport S Khaidukov O Baidina V Bojenko E Moiseeva G Pazynina U Karsten N Nifant’ev J LePendu N Bovin (2003) ArticleTitleInvolvement of the Galbeta1 – 3GalNAcbeta structure in the recognition of apoptotic bodies by THP-1 cells Eur J Cell Biol 82 295–302 Occurrence Handle10.1078/0171-9335-00314 Occurrence Handle12868597
H Leffler (2001) Galectins structure and function – a synopsis in Mammalian Carbohydrate recognition systems R Crocker Paul (Eds) Mammalian Carbohydrate Recognition Systems Springer-Verlag Berlin–Heidelberg 57–83
EV Korobko LP Saschenko EB Prockhorchouk IV Korobko NV Gnuchev SL Kiselev (1999) ArticleTitleResistance to tumour necrosis factor induced apoptosis in vitro correlates with high metastatic capacity of cells Immunol Lett 67 71–76 Occurrence Handle10.1016/S0165-2478(98)00143-6 Occurrence Handle10232385
HC Siebert S Andre SY Lu M Frank H Kaltner JA van Kuik EY Korchagina N Bovin E Tajkhorshid R Kaptein JFG Vliegenthart CW von der Leith J Jimenez-Barbero J Kopitz HJ Gabius (2003) ArticleTitleUnique conformer selection of the human growth-regulatory lectin galectin-1 for ganglioside GM1 versus bacterial toxins Biochemistry 42 14762–14773 Occurrence Handle10.1021/bi035477c Occurrence Handle14674750
I Schmidt CH Uittenbogaart JV Giorgi (1991) ArticleTitleA gentle fixation and permeabilization method for combined cell surface and intracellular staining with improved precision in DNA quantification Cytometry 12 279–285 Occurrence Handle10.1002/cyto.990120312 Occurrence Handle1709845
Squartini F, Pingitore R: Tumours of the mammary gland. In: Turusov VA (ed) Pathology of Tumours in Laboratory Animals, Lyon, 1994, Vol. 2, pp 84–92.
Z Kinkor I Svitakova A Ryska R Kodet P Hrabal (2002) ArticleTitleMetaplastic spindle-cell (fibromatosis-like) carcinoma of the breast-report of 4 cases Cesk Patol 38 164–168 Occurrence Handle12629863
M Kriege CT Brekelmans C Boetes PE Besnard HM Zonderland IM Obdeijn RA Manoliu T Kok H Peterse MM Tilanus-Linthorst SH Muller S Meijer JC Oosterwijk LV Beex RA Tollenaar HJ Koning Particlede EJ Rutgers JG Klijn (2004) ArticleTitleEfficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition N Engl J Med 351 427–437 Occurrence Handle10.1056/NEJMoa031759 Occurrence Handle15282350
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this artcile can be found at http://dx.doi.org/10.1007/s10549-005-1747-z
Rights and permissions
About this article
Cite this article
Moiseeva, E.V., Rapoport, E.M., Bovin, N.V. et al. Galectins as markers of aggressiveness of mouse mammary carcinoma: towards a lectin target therapy of human breast cancer. Breast Cancer Res Treat 91, 227–241 (2005). https://doi.org/10.1007/s10549-005-0289-8
Issue Date:
DOI: https://doi.org/10.1007/s10549-005-0289-8